ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IMMX Immix Biopharma Inc

2.19
-0.11 (-4.78%)
May 22 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -1.33M-1.56M-1.53M-3.79M-2.52M-3.72M-4.52M-5.38M
Pre Tax Income -1.33M-1.56M-1.53M-3.79M-2.49M-3.59M-4.34M-5.15M
Net Income -1.33M-1.56M-1.54M-3.8M-2.48M-3.58M-4.28M-5.09M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -1.33M-1.56M-1.53M-3.79M-2.52M-3.72M-4.52M-5.38M
EBITDA -1.33M-1.56M-1.53M-3.79M-2.52M-3.72M-4.52M-5.37M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -842k-454k-1.35M-8.22M-16.14M
Pre Tax Income -952k-1.13M-24.38M-8.22M-15.57M
Net Income -973k-1.15M-24.38M-8.23M-15.43M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -0.432-0.51-1.469-0.477-0.664
EBIT -842k-453k-1.44M-8.22M-16.14M
EBITDA -841k-452k-1.35M-8.22M-16.14M